{"id":26690,"date":"2025-12-19T10:55:34","date_gmt":"2025-12-19T09:55:34","guid":{"rendered":"https:\/\/www.unither-pharma.com\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/"},"modified":"2026-02-03T18:04:43","modified_gmt":"2026-02-03T17:04:43","slug":"pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo","status":"publish","type":"post","link":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/","title":{"rendered":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO"},"content":{"rendered":"<p id=\"ember895\" class=\"ember-view reader-text-block__paragraph\">Le mois dernier, le Club Sant\u00e9 Chine r\u00e9unissait les acteurs fran\u00e7ais engag\u00e9s sur le march\u00e9 chinois pour d\u00e9crypter les tendances qui red\u00e9finissent la sant\u00e9 mondiale. Digitalisation, silver economy, nouvelles dynamiques industrielles. Invit\u00e9e de la session, Ni Zeng, Responsable de la valorisation des services innovation et d\u00e9veloppement chez Unither, a partag\u00e9 son analyse d\u2019un march\u00e9 devenu central pour les entreprises pharmaceutiques et pour les CDMO qui misent sur le co-d\u00e9veloppement.<\/p>\n<h3 id=\"ember896\" class=\"ember-view reader-text-block__heading-3\">Pourquoi la Chine est-elle un march\u00e9 important pour Unither ?<\/h3>\n<p id=\"ember897\" class=\"ember-view reader-text-block__paragraph\">La Chine est un march\u00e9 cl\u00e9 pour Unither. Depuis la cr\u00e9ation de sa premi\u00e8re filiale \u00e0 Wuhan en 2016 et l\u2019acquisition d\u2019une usine \u00e0 Nanjing en 2020. L\u2019entreprise s\u2019est engag\u00e9e \u00e0 r\u00e9pondre aux besoins croissants du pays notamment en ophtalmologie et ainsi dans le traitement contre les maladies respiratoires.<\/p>\n<h3 id=\"ember898\" class=\"ember-view reader-text-block__heading-3\">Quel impact ont les politiques nationales sur l\u2019industrie pharmaceutique locale ?<\/h3>\n<p id=\"ember899\" class=\"ember-view reader-text-block__paragraph\">Dans le cadre d\u2019Unither, on voit que dans le contexte des politiques nationales obligeant l\u2019\u00e9valuation des m\u00e9dicaments g\u00e9n\u00e9riques sur son efficacit\u00e9 et sur sa qualit\u00e9 et notamment aussi avec la politique du VBP (Volume Based Procurement). Les laboratoires chinois ont une volont\u00e9 forte \u00e0 se diff\u00e9rencier en termes de produits.<\/p>\n<h3 id=\"ember900\" class=\"ember-view reader-text-block__heading-3\">Quelles sont les particularit\u00e9s du march\u00e9 ophtalmique chinois ?<\/h3>\n<p id=\"ember901\" class=\"ember-view reader-text-block__paragraph\">Il faut savoir aujourd\u2019hui le march\u00e9 des m\u00e9dicaments ophtalmiques en Chine a d\u00e9pass\u00e9 les 40 milliards de yuan malgr\u00e9 l\u2019impact du VBP. Actuellement, la plupart des collyres vendus en Chine sont en flacon multidoses contenant des conservateurs ce qui peut provoquer des effets ind\u00e9sirables quand il s\u2019agit d\u2019un usage r\u00e9p\u00e9t\u00e9. Le passage au format unidose sans conservateur r\u00e9pond \u00e0 un r\u00e9el besoin m\u00e9dical et s\u2019inscrit \u00e9galement dans la strat\u00e9gie de diff\u00e9renciation de nos clients.<\/p>\n<h3 id=\"ember902\" class=\"ember-view reader-text-block__heading-3\">Comment Unither accompagne-t-il ces besoins croissants ?<\/h3>\n<p id=\"ember903\" class=\"ember-view reader-text-block__paragraph\">Unither a d\u00e9j\u00e0 investi dans les quatre lignes de production en BFS qui repr\u00e9sentent 400 millions de doses par an afin d\u2019accompagner nos clients chinois et les clients internationaux pour leur croissance en Chine. Notre plan est de doubler cette capacit\u00e9 dans les cinq prochaines ann\u00e9es afin de r\u00e9pondre aux besoins du march\u00e9.<\/p>\n<h3 id=\"ember904\" class=\"ember-view reader-text-block__heading-3\">Comment voyez-vous la transformation du secteur pharmaceutique chinois ?<\/h3>\n<p id=\"ember905\" class=\"ember-view reader-text-block__paragraph\">Comme beaucoup ont \u00e9chang\u00e9 pendant la table ronde maintenant la Chine est pass\u00e9e d\u2019un r\u00f4le d\u2019un simple fabricant de m\u00e9dicaments g\u00e9n\u00e9riques \u00e0 celui de d\u00e9veloppeur de m\u00e9dicaments innovants.<\/p>\n<h3 id=\"ember906\" class=\"ember-view reader-text-block__heading-3\">Qu\u2019est-ce que cela repr\u00e9sente pour Unither en tant que CDMO et partenaire de co-d\u00e9veloppement ?<\/h3>\n<p id=\"ember907\" class=\"ember-view reader-text-block__paragraph\">Pour le cadre d\u2019Unither, c\u2019est une tr\u00e8s belle opportunit\u00e9 que ce soit pour notre activit\u00e9 CDMO sur le march\u00e9 local ou pour des partenariats de co-d\u00e9veloppement qui aident l\u2019entreprise chinoise \u00e0 introduire des nouveaux produits innovants sur les march\u00e9s mondiaux.<\/p>\n<p id=\"ember908\" class=\"ember-view reader-text-block__paragraph\">Vous souhaitez en savoir plus sur nos services de co-d\u00e9veloppement et de out-licensing ? <a class=\"BZlYAjikHPGRJsJDVXcEAIgyCHVdMWfWWELYvU \" tabindex=\"0\" href=\"https:\/\/www.unither-pharma.fr\/contact\/\" target=\"_self\" data-test-app-aware-link=\"\">Contactez-nous<\/a> !<\/p>\n<p>&nbsp;<\/p>\n<h3 data-start=\"3039\" data-end=\"3079\">\u00c0 propos d\u2019Unither Pharmaceuticals<\/h3>\n<p data-start=\"3081\" data-end=\"3657\">Unither Pharmaceuticals est un sous-traitant pharmaceutique sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et la fabrication de formulations liquides en unidoses et multidoses (notamment des collyres, des solutions salines, des m\u00e9dicaments pour l\u2019asthme en unidoses BFS et des sticks oraux) pour les laboratoires pharmaceutiques innovants et fabricants de g\u00e9n\u00e9riques. Avec 2 305 employ\u00e9s et huit sites de production en France, aux \u00c9tats-Unis, au Br\u00e9sil et en Chine, ainsi qu\u2019un centre R&amp;D en France, Unither Pharmaceuticals a r\u00e9alis\u00e9 un chiffre d\u2019affaires de 522 millions d\u2019euros en 2024.<\/p>\n<p data-start=\"3659\" data-end=\"3683\"><a href=\"http:\/\/www.unither-pharma.com\/?__hstc=52294006.b90fb330c36ee805d73e0d4b785ba92b.1725461238885.1763652245191.1764171313670.62&amp;__hssc=52294006.112.1764171313670&amp;__hsfp=3535019593\" target=\"_new\" rel=\"noopener\" data-start=\"3659\" data-end=\"3681\">www.unither-pharma.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le mois dernier, le Club Sant\u00e9 Chine r\u00e9unissait les acteurs fran\u00e7ais engag\u00e9s sur le march\u00e9 chinois pour d\u00e9crypter les tendances qui red\u00e9finissent la sant\u00e9 mondiale. Digitalisation, silver economy, nouvelles dynamiques industrielles. Invit\u00e9e de la session, Ni Zeng, Responsable de la valorisation des services innovation et d\u00e9veloppement chez Unither, a partag\u00e9 son analyse d\u2019un march\u00e9 devenu [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":26941,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-26690","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-informations"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither<\/title>\n<meta name=\"description\" content=\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither\" \/>\n<meta property=\"og:description\" content=\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\" \/>\n<meta property=\"og:site_name\" content=\"Unither\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-19T09:55:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-03T17:04:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"406\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UnitherPharma\" \/>\n<meta name=\"twitter:site\" content=\"@UnitherPharma\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28\"},\"headline\":\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO\",\"datePublished\":\"2025-12-19T09:55:34+00:00\",\"dateModified\":\"2026-02-03T17:04:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\"},\"wordCount\":600,\"publisher\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png\",\"articleSection\":[\"Informations\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\",\"name\":\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither\",\"isPartOf\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png\",\"datePublished\":\"2025-12-19T09:55:34+00:00\",\"dateModified\":\"2026-02-03T17:04:43+00:00\",\"description\":\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither\",\"breadcrumb\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage\",\"url\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png\",\"contentUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png\",\"width\":406,\"height\":300,\"caption\":\"Article - Chine\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.unither-pharma.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#website\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/\",\"name\":\"Unither\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.unither-pharma.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\",\"name\":\"Unither\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png\",\"contentUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png\",\"width\":514,\"height\":252,\"caption\":\"Unither\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/UnitherPharma\",\"https:\/\/www.linkedin.com\/company\/unither-pharmaceuticals\/\",\"https:\/\/www.youtube.com\/channel\/UCHaTbYrnICFU1MiLwNsKjMA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28\",\"name\":\"admin\",\"sameAs\":[\"https:\/\/www.unither-pharma.com\"],\"url\":\"https:\/\/www.unither-pharma.com\/fr\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","description":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/","og_locale":"fr_FR","og_type":"article","og_title":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","og_description":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","og_url":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/","og_site_name":"Unither","article_published_time":"2025-12-19T09:55:34+00:00","article_modified_time":"2026-02-03T17:04:43+00:00","og_image":[{"width":406,"height":300,"url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@UnitherPharma","twitter_site":"@UnitherPharma","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#article","isPartOf":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/"},"author":{"name":"admin","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28"},"headline":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO","datePublished":"2025-12-19T09:55:34+00:00","dateModified":"2026-02-03T17:04:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/"},"wordCount":600,"publisher":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png","articleSection":["Informations"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/","url":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/","name":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","isPartOf":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png","datePublished":"2025-12-19T09:55:34+00:00","dateModified":"2026-02-03T17:04:43+00:00","description":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO | Unither","breadcrumb":{"@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#primaryimage","url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png","contentUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/12\/Vignette-article-1.png","width":406,"height":300,"caption":"Article - Chine"},{"@type":"BreadcrumbList","@id":"https:\/\/www.unither-pharma.com\/fr\/pourquoi-la-chine-est-devenue-un-marche-cle-pour-lophtalmologie-et-les-cdmo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unither-pharma.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Pourquoi la Chine est devenue un march\u00e9 cl\u00e9 pour l\u2019ophtalmologie et les CDMO"}]},{"@type":"WebSite","@id":"https:\/\/www.unither-pharma.com\/fr\/#website","url":"https:\/\/www.unither-pharma.com\/fr\/","name":"Unither","description":"","publisher":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unither-pharma.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.unither-pharma.com\/fr\/#organization","name":"Unither","url":"https:\/\/www.unither-pharma.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png","contentUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png","width":514,"height":252,"caption":"Unither"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/UnitherPharma","https:\/\/www.linkedin.com\/company\/unither-pharmaceuticals\/","https:\/\/www.youtube.com\/channel\/UCHaTbYrnICFU1MiLwNsKjMA"]},{"@type":"Person","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28","name":"admin","sameAs":["https:\/\/www.unither-pharma.com"],"url":"https:\/\/www.unither-pharma.com\/fr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/26690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/comments?post=26690"}],"version-history":[{"count":1,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/26690\/revisions"}],"predecessor-version":[{"id":26691,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/26690\/revisions\/26691"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/media\/26941"}],"wp:attachment":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/media?parent=26690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/categories?post=26690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/tags?post=26690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}